SELESTIAL: Trial of Insulin to Control Blood Sugar After Acute Stroke Using Magnetic Resonance Imaging (MRI) End-Points

NCT00124826 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Acute Stroke
Hyperglycemia

Interventions

DRUG: Insulin

Sponsor

University of Glasgow

Collaborators

[object Object]
[object Object]